The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed

Tumor-specific T helper (Th) cells have a central role in the immune response against cancer. However, there exist distinct Th cell subsets with very different and antagonizing properties. Some Th subsets such as Th1 protect against cancer, while others (Th2, T regulatory/Treg) are considered detrim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Astri Frafjord, Linn Buer, Clara Hammarström, Henrik Aamodt, Per Reidar Woldbæk, Odd Terje Brustugun, Åslaug Helland, Inger Øynebråten, Alexandre Corthay
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Th1
Acceso en línea:https://doaj.org/article/2b51742e4f6f426790d9afff1e6a5702
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b51742e4f6f426790d9afff1e6a5702
record_format dspace
spelling oai:doaj.org-article:2b51742e4f6f426790d9afff1e6a57022021-11-18T07:54:24ZThe Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed1664-322410.3389/fimmu.2021.764596https://doaj.org/article/2b51742e4f6f426790d9afff1e6a57022021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.764596/fullhttps://doaj.org/toc/1664-3224Tumor-specific T helper (Th) cells have a central role in the immune response against cancer. However, there exist distinct Th cell subsets with very different and antagonizing properties. Some Th subsets such as Th1 protect against cancer, while others (Th2, T regulatory/Treg) are considered detrimental or of unknown significance (T follicular helper/Tfh, Th17). The Th composition of human solid tumors remains poorly characterized. Therefore, we established a four-color multiplex chromogenic immunohistochemical assay for detection of Th1, Th2, Th17, Tfh and Treg cells in human tumor sections. The method was used to analyze resected primary lung tumors from 11 patients with non-small cell lung cancer (NSCLC). Four microanatomical regions were investigated: tumor epithelium, tumor stroma, peritumoral tertiary lymphoid structures (TLS) and non-cancerous distal lung tissue. In tumor epithelium and stroma, most CD4+ T cells identified had either a Th2 (GATA-3+CD3+CD8-) or Treg (FOXP3+CD3+CD8-) phenotype, whereas only low numbers of Th1, Th17, and Tfh cells were observed. Similarly, Th2 was the most abundant Th subset in TLS, followed by Treg cells. In sharp contrast, Th1 was the most frequently detected Th subset in non-cancerous lung tissue from the same patients. A higher Th1:Th2 ratio in tumor stroma was found to be associated with increased numbers of intratumoral CD8+ T cells. The predominance of Th2 and Treg cells in both tumor stroma and tumor epithelium was consistent for all the 11 patients investigated. We conclude that human primary NSCLC tumors are Th2-skewed and contain numerous Treg cells. If human tumors are Th2-skewed, as our data in NSCLC suggest, reprogramming the type of immune response from a detrimental Th2 to a beneficial Th1 may be critical to increase the response rate of immunotherapy.Astri FrafjordLinn BuerClara HammarströmHenrik AamodtHenrik AamodtPer Reidar WoldbækOdd Terje BrustugunOdd Terje BrustugunÅslaug HellandÅslaug HellandÅslaug HellandInger ØynebråtenAlexandre CorthayAlexandre CorthayFrontiers Media S.A.articleCD4 T cellscancer immunosurveillanceclass of immune responsemultiplex immunohistochemistryNSCLCTh1Immunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic CD4 T cells
cancer immunosurveillance
class of immune response
multiplex immunohistochemistry
NSCLC
Th1
Immunologic diseases. Allergy
RC581-607
spellingShingle CD4 T cells
cancer immunosurveillance
class of immune response
multiplex immunohistochemistry
NSCLC
Th1
Immunologic diseases. Allergy
RC581-607
Astri Frafjord
Linn Buer
Clara Hammarström
Henrik Aamodt
Henrik Aamodt
Per Reidar Woldbæk
Odd Terje Brustugun
Odd Terje Brustugun
Åslaug Helland
Åslaug Helland
Åslaug Helland
Inger Øynebråten
Alexandre Corthay
Alexandre Corthay
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
description Tumor-specific T helper (Th) cells have a central role in the immune response against cancer. However, there exist distinct Th cell subsets with very different and antagonizing properties. Some Th subsets such as Th1 protect against cancer, while others (Th2, T regulatory/Treg) are considered detrimental or of unknown significance (T follicular helper/Tfh, Th17). The Th composition of human solid tumors remains poorly characterized. Therefore, we established a four-color multiplex chromogenic immunohistochemical assay for detection of Th1, Th2, Th17, Tfh and Treg cells in human tumor sections. The method was used to analyze resected primary lung tumors from 11 patients with non-small cell lung cancer (NSCLC). Four microanatomical regions were investigated: tumor epithelium, tumor stroma, peritumoral tertiary lymphoid structures (TLS) and non-cancerous distal lung tissue. In tumor epithelium and stroma, most CD4+ T cells identified had either a Th2 (GATA-3+CD3+CD8-) or Treg (FOXP3+CD3+CD8-) phenotype, whereas only low numbers of Th1, Th17, and Tfh cells were observed. Similarly, Th2 was the most abundant Th subset in TLS, followed by Treg cells. In sharp contrast, Th1 was the most frequently detected Th subset in non-cancerous lung tissue from the same patients. A higher Th1:Th2 ratio in tumor stroma was found to be associated with increased numbers of intratumoral CD8+ T cells. The predominance of Th2 and Treg cells in both tumor stroma and tumor epithelium was consistent for all the 11 patients investigated. We conclude that human primary NSCLC tumors are Th2-skewed and contain numerous Treg cells. If human tumors are Th2-skewed, as our data in NSCLC suggest, reprogramming the type of immune response from a detrimental Th2 to a beneficial Th1 may be critical to increase the response rate of immunotherapy.
format article
author Astri Frafjord
Linn Buer
Clara Hammarström
Henrik Aamodt
Henrik Aamodt
Per Reidar Woldbæk
Odd Terje Brustugun
Odd Terje Brustugun
Åslaug Helland
Åslaug Helland
Åslaug Helland
Inger Øynebråten
Alexandre Corthay
Alexandre Corthay
author_facet Astri Frafjord
Linn Buer
Clara Hammarström
Henrik Aamodt
Henrik Aamodt
Per Reidar Woldbæk
Odd Terje Brustugun
Odd Terje Brustugun
Åslaug Helland
Åslaug Helland
Åslaug Helland
Inger Øynebråten
Alexandre Corthay
Alexandre Corthay
author_sort Astri Frafjord
title The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
title_short The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
title_full The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
title_fullStr The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
title_full_unstemmed The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
title_sort immune landscape of human primary lung tumors is th2 skewed
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/2b51742e4f6f426790d9afff1e6a5702
work_keys_str_mv AT astrifrafjord theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT linnbuer theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT clarahammarstrom theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT henrikaamodt theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT henrikaamodt theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT perreidarwoldbæk theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT oddterjebrustugun theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT oddterjebrustugun theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT ingerøynebraten theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT alexandrecorthay theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT alexandrecorthay theimmunelandscapeofhumanprimarylungtumorsisth2skewed
AT astrifrafjord immunelandscapeofhumanprimarylungtumorsisth2skewed
AT linnbuer immunelandscapeofhumanprimarylungtumorsisth2skewed
AT clarahammarstrom immunelandscapeofhumanprimarylungtumorsisth2skewed
AT henrikaamodt immunelandscapeofhumanprimarylungtumorsisth2skewed
AT henrikaamodt immunelandscapeofhumanprimarylungtumorsisth2skewed
AT perreidarwoldbæk immunelandscapeofhumanprimarylungtumorsisth2skewed
AT oddterjebrustugun immunelandscapeofhumanprimarylungtumorsisth2skewed
AT oddterjebrustugun immunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland immunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland immunelandscapeofhumanprimarylungtumorsisth2skewed
AT aslaughelland immunelandscapeofhumanprimarylungtumorsisth2skewed
AT ingerøynebraten immunelandscapeofhumanprimarylungtumorsisth2skewed
AT alexandrecorthay immunelandscapeofhumanprimarylungtumorsisth2skewed
AT alexandrecorthay immunelandscapeofhumanprimarylungtumorsisth2skewed
_version_ 1718422775447683072